For Research Use Only. Semax is intended strictly for in vitro and preclinical animal research. It is not approved for human use, is not a drug, and should never be administered to humans.
Recent Peer-Reviewed Research on Semax Neurobiology
Investigators sourcing Semax for animal model work should be familiar with the two primary lines of mechanistic literature that frame nearly all current research questions in this space.
The BDNF/TrkB axis is the most cited mechanism for Semax's cognitive and neuroprotective effects in rodent models. The foundational paper is Dolotov and colleagues at ScienceDirect's Brain Research, which demonstrated that a single intranasal administration of Semax at 50 micrograms per kilogram body weight produced a 1.4-fold increase in BDNF protein in the rat hippocampus, accompanied by a 1.6-fold increase in TrkB tyrosine phosphorylation and a 3-fold induction of exon III BDNF mRNA. The time course peaked between 1 and 3 hours post-administration and returned to baseline by 24 hours, which is the temporal window most subsequent behavioral studies design their training and probe trials around. A complementary paper from Shadrina and colleagues on neurotrophin gene expression in rat brain following Semax administration at ScienceDirect extended these findings to NGF and trkA expression and characterized the regional specificity of the response across the hippocampus, frontal cortex, and basal forebrain. Together those two papers establish the molecular endpoints that any new behavioral or ischemic study using Semax should reference for its sampling schedule.
For the broader Russian preclinical and clinical research program that gave rise to Semax, the Frontiers in Aging review on therapeutic peptides in gerontology summarizes the current state of the heptapeptide literature in the context of related Russian neuropeptide development programs (including Selank and the broader regulatory peptide family from the Institute of Molecular Genetics in Moscow). The Nature Reviews Neuroscience subject collection on neuropeptides at Nature is a useful entry point for investigators integrating Semax research into broader neurotrophic factor or cognitive enhancement research programs.
These mechanistic anchors matter for sourcing decisions because the published BDNF and TrkB effects are sensitive to sequence integrity. The methionine at position 1 of the Met-Glu-His-Phe-Pro-Gly-Pro sequence is the most oxidation-prone residue, and any methionine sulfoxide contamination in the supplied material will shift the observed dose-response curve relative to the published literature. That is why the Semax 10mg product page lists both HPLC purity and mass spectrometry verification of the intact methionine on every batch COA, rather than the HPLC purity alone that some suppliers report.
What Research Grade Semax Supply Requires
Semax is a seven amino acid synthetic peptide derived from ACTH with the sequence Met Glu His Phe Pro Gly Pro. The specific sequence has been carefully characterized in relation to its biological activity, and research grade supply has to confirm sequence identity with appropriate analytical methods.
The peptide is relatively short and chemically straightforward, but the sequence includes methionine that is susceptible to oxidation. Research grade supply has to ensure that the supplied material has the intact methionine residue and that storage conditions maintain this state. Midwest Peptide supplies Semax 10mg with third party certificates of analysis that address these requirements.
Sourcing Criteria for Research Grade Semax
Third party certificate of analysis. Independent analytical verification with lot specific values for sequence, mass, and purity.
Purity specification. Research grade Semax is supplied at a minimum of ninety five percent HPLC purity.
Mass confirmation. Mass spectrometric analysis confirming the correct heptapeptide mass including intact methionine.
Sequence verification. Tandem mass spectrometry confirming the specific seven amino acid sequence.
Lot traceability. Every vial carries a lot number that traces to the production batch.
Research use only compliance. The Semax research cluster covers the preclinical research applications including ACTH origins, BDNF NGF research, cognitive research, intranasal delivery research, ischemia research, and attention research.
Shipping. Domestic shipping from Mission, Kansas through ShipStation and UPS.
Payment flexibility. Zelle (five percent discount), CashApp, Venmo, Azeban Pay, and Coinbase Commerce.
Research support. Direct support through 636-734-2390.
Red Flags When Evaluating Semax Suppliers
No sequence confirmation. A certificate showing only mass without sequence confirmation is inadequate for a peptide where sequence specificity matters.
Purity below research grade or unspecified. Ninety five percent HPLC purity minimum with lot specific values.
Internal certificate only. Third party verification is the research grade standard.
Health claims or implied human use. Suppliers making such claims operate outside the research use only framework.
Inadequate methionine handling. The methionine residue requires proper storage conditions, and a supplier that does not address this in formulation and shipping is not positioned for rigorous research supply.
Opaque supplier. Legitimate research peptide suppliers have known physical locations.
What Semax Is Studied For in Research
The Semax research cluster covers the full landscape. The short summary is that Semax is studied in rodent research models for effects on cognitive function including memory and attention, stroke recovery and ischemic neuroprotection, BDNF and NGF neurotrophic factor signaling, and the broader nootropic effects that have supported extensive Russian preclinical and clinical research on the peptide.
Related research with other nootropic peptides is supported by the parallel Midwest Peptide catalog offering of Selank 10mg. The Selank versus Semax comparison article discusses the comparative pharmacology of these two Russian research peptides.